About   Help   FAQ
Melm3C57BL/6J
QTL Variant Detail
Summary
QTL variant: Melm3C57BL/6J
Name: melanoma modifier 3; C57BL/6J
MGI ID: MGI:3036033
QTL: Melm3  Location: unknown  Genetic Position: Chr11, Syntenic
Variant
origin
Strain of Specimen:  C57BL/6J
Variant
description
Allele Type:    QTL
Mutation:    Undefined
    This allele confers melanoma susceptibility compared to BALB/cJ. (J:66211)
Inheritance:    Recessive
Phenotypes
Loading...
View phenotypes and curated references for all genotypes (concatenated display).
Notes

Mapping and Phenotype information for this QTL, its variants and associated markers

J:66211

Line 304 is a RET transgene that was maintained in a (C57BL/6 x BALB/c)F1 background. The RET transgenic line is a model for melanoma development A partial congenic line was developed to N3 by crossing (C57BL/6 x BALB/c)F1 transgenic carriers to C57BL/6J. Importantly these N3 congenics were heterozygous for the RET transgene. The N3 RET congenics were crossed to BALB/c and then backcrossed to the N3 RET transgenic line producing 195 backcross mice for the purpose to scan the genome for melanoma phenotypes. A marker on mouse Chromosome 11 was associated with melanoma tumor latency. Melm3 was significantly associated with D11Mit231 (LOD 3.7). Authors suggest Egfr-rs and Il12b as candidates for Melm3 Two other markers, Melm1 and Melm2 were associated with mouse Chromosome 1

References
Original:  J:66211 Dragani TA, et al., Mapping of melanoma modifier loci in RET transgenic mice. Jpn J Cancer Res. 2000 Nov;91(11):1142-7
All:  1 reference(s)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory